Tci Wealth Advisors, Inc. Ionis Pharmaceuticals Inc Transaction History

Tci Wealth Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$25.61 - $35.1 $3,559 - $4,878	-139 Reduced 79.89%	35 $1,000
Q3 2021 Oct 29, 2021	BUY	$33.54 - $40.55 $1,006 - $1,216	30 Added 20.83%	174 $6,000
Q2 2021 Aug 02, 2021	BUY	$34.54 - $47.25 $3,764 - $5,150	109 Added 311.43%	144 $6,000
Q2 2020 Jul 20, 2020	SELL	$46.85 - $61.05 $843 - $1,098	-18 Reduced 33.96%	35 $2,000
Q4 2019 Jan 27, 2020	SELL	$53.85 - $65.27 $376 - $456	-7 Reduced 11.67%	53 $3,000
Q3 2019 Oct 17, 2019	SELL	$59.06 - $72.15 $354 - $432	-6 Reduced 9.09%	60 $4,000
Q4 2018 Jan 17, 2019	SELL	$43.37 - $59.54 $390 - $535	-9 Reduced 12.0%	66 $4,000
Q3 2018 Nov 02, 2018	SELL	$42.88 - $53.7 $771 - $966	-18 Reduced 19.35%	75 $4,000
Q2 2018 Jul 27, 2018	BUY	$40.53 - $50.7 $1,094 - $1,368	27 Added 40.91%	93 $4,000
Q2 2017 Aug 10, 2017	BUY	N/A	66	66 $3,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.